The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127142461 12714246 1 I 20160509 20160905 20160905 PER US-JAZZ-2016-US-008666 JAZZ 0.00 F Y 0.00000 20160905 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127142461 12714246 1 PS XYREM SODIUM OXYBATE 1 Oral 2.25 G, BID 21196 2.25 G ORAL SOLUTION
127142461 12714246 2 SS XYREM SODIUM OXYBATE 1 Oral DOSE ADJUSTMENTS 21196 ORAL SOLUTION
127142461 12714246 3 SS XYREM SODIUM OXYBATE 1 Oral 6 G, FIRST DOSE 21196 6 G ORAL SOLUTION
127142461 12714246 4 SS XYREM SODIUM OXYBATE 1 Oral 3 G, SECOND DOSE 21196 3 G ORAL SOLUTION
127142461 12714246 5 SS EFFEXOR VENLAFAXINE HYDROCHLORIDE 1 Y 0
127142461 12714246 6 SS RITALIN METHYLPHENIDATE HYDROCHLORIDE 1 UNK U 0
127142461 12714246 7 C Nortriptyline hcl NORTRIPTYLINE HYDROCHLORIDE 1 U 0
127142461 12714246 8 C ABILIFY ARIPIPRAZOLE 1 U 0
127142461 12714246 9 C ATIVAN LORAZEPAM 1 U 0
127142461 12714246 10 C Ezfe 2 U 0
127142461 12714246 11 C PLAQUENIL HYDROXYCHLOROQUINE SULFATE 1 U 0
127142461 12714246 12 C Probiotica PROBIOTICS NOS 1 U 0
127142461 12714246 13 C BRINTELLIX VORTIOXETINE HYDROBROMIDE 1 U 0
127142461 12714246 14 C CIMZIA CERTOLIZUMAB PEGOL 1 U 0
127142461 12714246 15 C CRYSELLE ETHINYL ESTRADIOLNORGESTREL 1 U 0
127142461 12714246 16 C LEXAPRO ESCITALOPRAM OXALATE 1 U 0
127142461 12714246 17 C PRILOSEC OMEPRAZOLE MAGNESIUM 1 U 0
127142461 12714246 18 C PROAIR HFA ALBUTEROL SULFATE 1 U 0
127142461 12714246 19 C Hydrocodone/acetaminophen ACETAMINOPHENHYDROCODONE 1 U 0
127142461 12714246 20 C CEPHALEXIN. CEPHALEXIN 1 U 0
127142461 12714246 21 C HUMIRA ADALIMUMAB 1 U 0
127142461 12714246 22 C GEODON ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE 1 U 0
127142461 12714246 23 C VITAMIN D3 CHOLECALCIFEROL 1 U 0
127142461 12714246 24 C ASACOL HD MESALAMINE 1 U 0
127142461 12714246 25 C CLARITIN LORATADINE 1 U 0
127142461 12714246 26 C SYNTHROID LEVOTHYROXINE SODIUM 1 U 0
127142461 12714246 27 C AMLODIPINE BESYLATE. AMLODIPINE BESYLATE 1 U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127142461 12714246 1 Narcolepsy
127142461 12714246 5 Product used for unknown indication
127142461 12714246 6 Product used for unknown indication

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
127142461 12714246 Condition aggravated
127142461 12714246 Depression
127142461 12714246 Hypertension

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127142461 12714246 1 201303 201303 0
127142461 12714246 3 201501 0
127142461 12714246 4 201501 0